Objectone Inform (535657)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at ₹14.42 versus book value ₹16.53, a P/B of 0.87 that provides a margin of safety if assets are genuine.
• Latest quarter turned profitable with ₹4 Cr sales and ₹1 Cr net profit, suggesting a possible earnings inflection.
• Reported profit growth of 111.11% indicates improving momentum from a depressed base.
• Piotroski F-Score of 6/9 points to reasonable short-term financial health.
• Positive ROCE of 9.12% shows the existing capital base is generating some operating return.

Concerns

• Trailing P/E of 0.00 and ROE of -1.20% mean TTM profitability is not established; one profitable quarter may be seasonal or one-off.
• Sales growth of -1.78% shows weak top line in a competitive, low-moat software consulting industry.
• Promoter holding and Debt/Equity are not available, creating serious transparency risks for a microcap.
• Zero dividend yield means returns rely entirely on price appreciation, and the 52W range of ₹6.20-₹14.42 highlights volatility.

AI Analysis

At ₹14.42, Objectone Inform trades at a discount to its book value of ₹16.53, a P/B of 0.87. That 13% gap makes a value investor stop and look. But as Graham said, price is what you pay, value is what you get. This is a microcap software consulting company with a ₹15 Cr market cap, and in this business, a durable moat is rare. Clients and people are the assets, not loyal franchises. The financial health is mixed. Trailing P/E is 0.00 and ROE is -1.20%, so the book is not currently earning an acceptable return. Sales have slipped -1.78%. The latest quarter shows ₹4 Cr sales and ₹1 Cr net profit, and reported profit growth of 111.11% sounds encouraging, but one quarter can mislead. Piotroski's F-Score of 6/9 gives some comfort, but not enough. There is no dividend, promoter holding is not disclosed, and the debt-equity figure is unavailable. For a small company, that lack of transparency is a real red flag. So what do I really own? A business selling below stated book with a possible earnings revival but no proven track record. This looks more like an asset play than a compounder. I would need to verify the actual book value—cash, receivables, intangibles, contingent liabilities—and see sustained profit before putting serious money to work. A cheap price is only a margin of safety if the underlying business is sound. Right now, the discount is real, but business quality is still unproven.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer